John K. Bielicki

Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides

Patricia G. Yancey, John K. Bielicki, William J. Johnson et al. · Biochemistry · 1995 · 189 citations

Life Sciences, Biochemistry, Molecular Biology +17

Increased Low-Density Lipoprotein Oxidation and Impaired High-Density Lipoprotein Antioxidant Defense Are Associated With Increased Macrophage Homing and Atherosclerosis in Dyslipidemic Obese Mice

Ann Mertens, Peter Verhamme, John K. Bielicki et al. · Circulation · 2003 · 176 citations · Full text

Life Sciences, Biochemistry, Inflammation +14

Apolipoprotein A-I_Milano and Apolipoprotein A-I_Paris Exhibit an Antioxidant Activity Distinct from That of Wild-Type Apolipoprotein A-I

John K. Bielicki, Michael N. Oda · Biochemistry · 2002 · 133 citations

Life Sciences, Biochemistry, Cardiovascular Genetics +16

A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice

John K. Bielicki, Haiyan Zhang, Yuan Cortez et al. · Journal of Lipid Research · 2010 · 130 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Weight Loss–Associated Induction of Peroxisome Proliferator–Activated Receptor-α and Peroxisome Proliferator–Activated Receptor-γ Correlate With Reduced Atherosclerosis and Improved Cardiovascular Function in Obese Insulin-Resistant Mice

Wim Verreth, Dieuwke De Keyzer, Michel Pelat et al. · Circulation · 2004 · 129 citations · Full text

Medicine, Cardiology, Endocrinology +17